Tissue Factor Science
Iconic Therapeutics is leveraging its deep insight into the role of tissue factor in inflammation and angiogenesis to develop breakthrough medicines for ophthalmology and oncology indications. Learn More function get_style () { return "none"; } function end_ () {
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $108.5M
Founded date: 2003
Investors 4
| Date | Name | Website |
| - | H.I.G. Cap... | higcapital... |
| - | H.I.G. Bio... | higbio.com |
| - | Georgia Re... | gra.org |
| - | H.I.G. Cap... | hig.com/ |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 10.08.2016 | Series C | $48.5M | - |
| 11.01.2016 | Series C | $40M | - |
| 16.04.2014 | Series B | $20M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 14.05.2019 | Zymeworks Enters its First ZymeLink™ Antibody-Drug Conjugate... | VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopha... | lumiravent... |
| 10.08.2016 | Iconic Therapeutics Announces Final Close of Series C Financ... | - | mpmcapital... |
| 09.08.2016 | Iconic Therapeutics Closes $10M Series C Financing | Iconic Therapeutics, a South San Francisco, CA-based clinical stage biopharmaceutical company dedica... | finsmes.co... |
| 09.08.2016 | Iconic Therapeutics Raises $48.5M Series C from H.I.G. BioHe... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Iconic Therapeutics, a clinical stage biopharmaceutica... | citybizlis... |
| 12.01.2016 | Iconic Therapeutics snags $40M for eye disease R&D | Iconic CEO William Greene South San Francisco's Iconic Therapeutics raised $40 million in Series C c... | fiercebiot... |
| 11.01.2016 | Iconic Therapeutics Closes $40M Series C Financing | Iconic Therapeutics, a South San Francisco, CA-based clinical stage biopharmaceutical company dedica... | finsmes.co... |
| 11.01.2016 | Iconic Therapeutics brings in $40M in Series C for new thera... | The financing came from existing investors MPM Capital, H.I.G. Capital and Lundbeckfund Ventures, as... | medcitynew... |
| 16.04.2014 | Iconic Therapeutics Raises $20 Million to Advance Clinical D... | - | mpmcapital... |
| 16.04.2014 | Iconic Therapeutics Raises $20M | ATLANTA, GA, Biotechnology company focused on developing therapeutics for serious eye disorders, a... | vcnewsdail... |
| 16.04.2014 | Iconic Therapeutics Completes $20M Series B-1 Equity Financi... | Iconic Therapeutics, Inc., a Atlanta, GA and South San Francisco, CA-based biotechnology company foc... | finsmes.co... |
Show more